INVOLVEMENT OF THE MISMATCH REPAIR SYSTEM IN TEMOZOLOMIDE-INDUCED APOPTOSIS

作者: Stefania D’Atri , Lucio Tentori , Pedro Miguel Lacal , Grazia Graziani , Elena Pagani

DOI: 10.1124/MOL.54.2.334

关键词: BiologyDNA fragmentationEtoposideApoptosisTemozolomideTopoisomerase-II InhibitorDNA mismatch repairMolecular biologyCancer researchCell cultureCell growth

摘要: Postreplicative mismatch repair plays a major role in mediating the cytotoxicity of agents generating O6-methylguanine DNA. We previously showed that methylating antitumor triazene compound, temozolomide, induces apoptosis and persistence DNA is required to trigger process. wanted test whether latter apoptotic signal dependent on functional system. To this end, we used two human lymphoblastoid cell lines (i.e., repair-proficient TK6 line its repair-deficient subline MT1) are both deficient repair. Temozolomide treatment cells brought about efficient growth inhibition, G2/M arrest, apoptosis, as indicated by results cytofluorimetric analysis 5-bromo-2'-deoxyuridine incorporation content evaluation fragmentation. The drug resulted also induction p53 p21/waf-1 protein expression. In contrast, MT1 were highly resistant no was observed. Importantly, could show not p53-dependent pathway; with etoposide, topoisomerase II inhibitor, expression lines. conclusion, demonstrate existence link between system exposed clinically relevant concentrations temozolomide. suggest response O6-guanine methylation involves

参考文章(40)
P R Walker, L Kokileva, M Sikorska, J LeBlanc, Detection of the initial stages of DNA fragmentation in apoptosis. BioTechniques. ,vol. 15, pp. 1032- 1040 ,(1993)
F. Oberhammer, J.W. Wilson, C. Dive, I.D. Morris, J.A. Hickman, A.E. Wakeling, P.R. Walker, M. Sikorska, Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. The EMBO Journal. ,vol. 12, pp. 3679- 3684 ,(1993) , 10.1002/J.1460-2075.1993.TB06042.X
Dan A. Liebermann, Maryla Krajewska, Stanislaw Krajewski, Hong Gang Wang, Barbara Hoffman, John C. Reed, H. K. Lin, Toshiyuki Miyashita, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene. ,vol. 9, pp. 1799- 1805 ,(1994)
A. J. Mcilwrath, A. R. M. Edlin, W. M. Gallagher, R. Brown, D. A. Anthoney, Microsatellite Instability, Apoptosis, and Loss of p53 Function in Drug-resistant Tumor Cells Cancer Research. ,vol. 56, pp. 1374- 1381 ,(1996)
Jia-wen Han, Cheryl A Dionne, Nancy L Kedersha, Victor S Goldmacher, None, p53 Status Affects the Rate of the Onset but not the Overall Extent of Doxorubicin-induced Cell Death in Rat-1 Fibroblasts Constitutively Expressing c-Myc Cancer Research. ,vol. 57, pp. 176- 182 ,(1997)
Thomas Anderson Henry, The plant alkaloids ,(2007)
J. M. Carethers, T. A. Kunkel, M. T. Hawn, M. Koi, G. Marra, Asad Umar, C. R. Boland, Evidence for a Connection between the Mismatch Repair System and the G2 Cell Cycle Checkpoint Cancer Research. ,vol. 55, pp. 3721- 3725 ,(1995)
Gilberti S, Bonmassar E, Graziani G, Tentori L, D'Atri S, Lacal Pm, Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines. Leukemia. ,vol. 9, pp. 1888- 1895 ,(1995)
Lili Liu, Sanford Markowitz, Stanton L. Gerson, Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Research. ,vol. 56, pp. 5375- 5379 ,(1996)